It has been shown that cancer-associated fibroblast-derived extracellular vesicle (EV) treats OSCC cells to acquire cisplatin resistance, by upregulating the expression of GATA-binding protein 1 (GATA1), a downstream factor of miR-876-3p. The gene discussed is GATA1; the disease is cancer.